跳至主要内容
临床试验/NCT01382862
NCT01382862已完成2 期

PHANTOM-S: The Pre-Hospital Acute Neurological Therapy and Optimization of Medical Care in Stroke Patients - Study

Charite University, Berlin, Germany2 个研究点 分布在 1 个国家目标入组 614 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
614
试验地点
2
主要终点
alarm-to-needle time

研究概览

简要总结

The purpose of this prospective study in acute ischemic stroke patients is to compare alarm-to-needle time during randomly allocated periods with and without availability of a specially staffed ambulance equipped with computed tomography (CT) and point-of care diagnostics. The investigators hypothesize that compared to regular care the investigators will reduce alarm-to-needle time by a minimum of 20 minutes by implementation of the stroke emergency mobile unit.

详细描述

Time from symptom onset is crucial for the effectiveness of intravenous thrombolysis in acute ischemic stroke patients. Many patients receive tissue Plasminogen Activator (tPA) with considerable delay. The investigators developed an ambulance equipped with a CT-scanner, point-of-care laboratory, teleradiological support and an emergency trained neurologist on board. In the Pre-Hospital Acute Neurological Therapy and Optimization of Medical care in Stroke patients (PHANTOM-S)-study the investigators aim at a reduction of the current alarm-to-needle time by pre-hospital use of tissue Plasminogen Activator in an ambulance.

The investigators hypothesize that compared to regular care we will reduce alarm-to-needle time by a minimum of 20 minutes by implementation of the stroke emergency mobile unit (STEMO).

This is a prospective study comparing randomly allocated periods with and without STEMO availability.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients whose emergency call prompted the suspicion of stroke within 4 hours of symptom onset or with undetermined time of onset in the dispatch center
  • Informed consent for documentation and follow-up provided by patients or legal representatives

排除标准

  • age < 18 years
  • pregnancy

结局指标

主要结局

alarm-to-needle time

时间窗: day 1

Primary endpoint of the study is the time between activation of the emergency medical service and initiation of thrombolysis (alarm-to-needle time).

次要结局

  • Proportion of stroke patients receiving tissue Plasminogen Activator (tPA)(day 1)
  • Functional outcomes(three months after symptom onset)
  • Serious adverse events(up to 3 months)
  • Mortality(up to three months)
  • other times(day 1)
  • Costs effectiveness will be assessed(15 months (coinciding with the anticipated date of the completion of the last follow-up))
  • symptomatic intracerebral hemorrhage(36 hours after symptom onset)
  • Special referral(day 1)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

PHANTOM-S: The Pre-Hospital Acute Neurological... | 临床试验